BOUTIGNON & PARTNERS

With over 30 years of experience in pharmaceutical R&D and 22 years as the CEO of Aptys, François Boutignon has been involved in designing and developing a wide range of products, beyond just peptides.

He helps his clients in the several steps of early development of their molecule:

• To define the formulation needed for regulatory as well as non regulatory pre-clinical studies;
• To select the CRO accordingly;
• To supervise the operation from the request for proposal to the delivery of the report;
• To define the TPP (target product profile) and QTPP (quality target product profile);
• To choose the right formulation and select the CDMO accordingly;
• To supervise the operation from the request for proposal to the delivery of the product.

And in addition, if the active substance is a peptide,

• To design and improve the structure;
• To select the supplier;

To manage the chemical development strategy according to the pre-clinical and clinical development journey of the peptide.